Suppr超能文献

原发性肺淋巴瘤患者生存预测的预后因素和列线图:一项 SEER 基于人群的研究。

Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study.

机构信息

School of Medicine, Faculty of Health and Medical Sciences, Taylor's University, Selangor, Malaysia.

Department of Otolaryngology, Menoufia University, Menoufia, Egypt.

出版信息

Leuk Lymphoma. 2019 Dec;60(14):3406-3416. doi: 10.1080/10428194.2019.1633636. Epub 2019 Jul 19.

Abstract

Primary pulmonary lymphomas (PPLs) are rare lymphoproliferative malignancies arising from the lungs. The prognostic factors and optimal management of PPL have not been clearly defined due to its rarity. This study sought to characterize the significant prognostic factors and develop a validated nomogram for individualized prediction of survival outcomes in patients with PPL. A total of 2325 patients diagnosed with PPL between 1983 and 2010 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Older age at diagnosis, males, Hispanic race, non-marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue histology, Ann Arbor stage IV were significantly associated with worse OS on multivariable analysis. All treatment modalities, including chemotherapy, surgery, and radiotherapy were independent predictors of survival on univariable analysis. The nomogram built demonstrated good discriminative ability and calibration, with the C-index of 0.690 and 0.730 in the training and validation cohorts, respectively.

摘要

原发性肺淋巴瘤(PPL)是一种罕见的肺部起源的淋巴增生性恶性肿瘤。由于其罕见性,PPL 的预后因素和最佳治疗方法尚未明确界定。本研究旨在确定显著的预后因素,并为 PPL 患者的生存结果建立一个经过验证的个体化预测列线图。使用监测、流行病学和最终结果(SEER)数据库,共确定了 1983 年至 2010 年间诊断为 PPL 的 2325 名患者。多变量分析显示,诊断时年龄较大、男性、西班牙裔、黏膜相关淋巴组织边缘区 B 细胞淋巴瘤组织学、Ann Arbor 分期 IV 与较差的 OS 显著相关。单变量分析显示,所有治疗方式,包括化疗、手术和放疗,均为生存的独立预测因素。建立的列线图在训练和验证队列中分别具有良好的区分能力和校准能力,C 指数分别为 0.690 和 0.730。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验